NCT05098678View on ClinicalTrials.gov

Zinc Supplementation and Behçet's Syndrome

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 22, 2020

Primary Completion Date

May 22, 2021

Study Completion Date

September 22, 2021

Conditions
Behcet Syndrome
Interventions
DIETARY_SUPPLEMENT

Zinc gluconate

120 mg each tablet containing 30 mg elemental zinc

DIETARY_SUPPLEMENT

Placebo

Placebo (microcrystalline cellulose): 1 tablet (120 mg each)

Trial Locations (1)

5166614756

Tabriz University of Medical Sciences, Tabriz

All Listed Sponsors
lead

Tabriz University of Medical Sciences

OTHER

NCT05098678 - Zinc Supplementation and Behçet's Syndrome | Biotech Hunter | Biotech Hunter